Epstein Secrets

hs ACUs. Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bark Wealth Management • • • n Francisco. CA USA From: Vaishali-P Mehta Sent: Wednesday, November 09, 2016 3:42 PM To: Andrew Gallivan Cc: Douglas Robertson; Stewart Oldfield; Thomas-B Mayer; Mark Gonzalez Sub

Risk Clients [I] Classification: For 'Memel use only Hello Andrew, Could I please get one more approval? This is for last months ACUs. Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bark Wealth Management • • • n Francisco. CA USA From: Vaishali-P Mehta Sent: Wednesday,

for last months ACUs. Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bark Wealth Management • • • n Francisco. CA USA From: Vaishali-P Mehta Sent: Wednesday, November 09, 2016 3:42 PM To: Andrew Gallivan Cc: Douglas Robertson; Stewart Oldfield; Thomas-B Mayer; Ma

Bank Wealth Management 101 California Street Suite 2400 San Francisco. CA USA From: Andrew Gallivan Sent: Thursday, December 01, 2016 9:55 AM To: Vaishali-P Mehta Subject: RE: MD Approval for ACUs for High Risk Clients [I) Classification: For Internal Use only Well aren't I the negligent one. Sorry f

Gallivan Subject: RE: MD Approval for ACUs for High Risk Clients [I) Classification: For internal use only no problem Andrew Thank you so much! Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bank Wealth Management 101 California Street Suite 2400 San Francisco. CA USA From: Andrew G

much! Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bank Wealth Management 101 California Street Suite 2400 San Francisco. CA USA From: Andrew Gallivan Sent: Thursday, December 01, 2016 9:55 AM To: Vaishali-P Mehta Subject: RE: MD Approval for ACUs for High Risk Clients [I)

o: Vaishali-P Mehta Subject: RE: MD approval for ACUs completed for High Risk Clients [I] Classification: For internal use only Approved. From: Vaishali-P Mehta Sent: Friday, April 07, 2017 2:21 PM To: Andrew Gallivan Subject: FW: MD approval for ACUs completed for High Risk Clients [I] Classifica

High Risk ACus which were completed? As I mentioned in the below email, this is the last email based approval I will be needing from you. Regards, Vaishali Mehta Deutsche Bark Wealth Management 101 California Street. Stile 2400. San Francisco. CA USA From: Vaishali-P Mehta Sent: Wednesday, April 05, 2017 1

ed approval I will be needing from you. Regards, Vaishali Mehta Deutsche Bark Wealth Management 101 California Street. Stile 2400. San Francisco. CA USA From: Vaishali-P Mehta Sent: Wednesday, April 05, 2017 12:23 PM To: Andrew Gallivan Cc: Mark Gonzalez; Rachel Maglicic; Stewart Oldfield; Brian P

will be needing from you. Regards, Vaishali Mehta Deutsche Bank Wealth Management 101 California Street. Suite 2400. San Francisco, CA USA From: Vaishali-P Mehta Sent: Wednesday, April 05, 2017 12:23 PM To: Andrew Gallivan Cc: Mark Gonzalez; Rachel Maglicic; Stewart Oldfield; Brian P Convey; Joanne

High Risk ACus which were completed? As I mentioned in the below email, this is the last email based approval I will be needing from you. Regards, Vaishali Mehta Deutsche Bank Wealth Management 101 California Street. Suite 2400. San Francisco, CA USA From: Vaishali-P Mehta Sent: Wednesday, April 05, 2017 1

ed approval I will be needing from you. Regards, Vaishali Mehta Deutsche Bank Wealth Management 101 California Street. Suite 2400. San Francisco, CA USA From: Vaishali-P Mehta Sent: Wednesday, April 05, 2017 12:23 PM To: Andrew Gallivan Cc: Mark Gonzalez; Rachel Maglicic; Stewart Oldfield; Brian P

Clients [I] Classification: For internal use only Well aren't I the negligent one. Sorry for not having addressed this last month. Approved From: Vaishali-P Mehta Sent: Thursday, December 01, 2016 9:36 AM To: Andrew Gallivan Subject: RE: MD Approval for ACUs for High Risk Clients [I] Classification:

isk Clients [I] Classification: For internal use only Hello Andrew, Could I please get one more approval? This is for last months ACUs. Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bank Wealth Management 101 California Street. Suite 2400. San Francisco. CA USA From: Vaisha

rds, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bank Wealth Management 101 California Street. Suite 2400. San Francisco. CA USA From: Vaishali-P Mehta Sent: Wednesday, November 09, 2016 3:42 PM To: Andrew Gallivan Cc: Douglas Robertson; Stewart Oldfield; Thomas-B Mayer; Ma

are Dynasty Trust 10/17/2016 There have been no new developments No changes Yes No Please let me know if you have any questions. Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bank Wealth Management 1 1 lir rni r 4 n Francisco. CA USA CONFIDENTIAL - PURSUANT TO FE

questions. Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bank Wealth Management 1 1 lir rni r 4 n Francisco. CA USA CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0070597 CONFIDENTIAL SDNY_GM_00216781 EFTA01375277

l be doing KYC updates/ Periodic Reviews which will require the MD signature via DB Force. Please let me know if you have any questions. Regards, Vaishali Mehta Deutsche Bank Wealth Management 101 California Street Suite 2400 San Francisco. CA USA CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0

se let me know if you have any questions. Regards, Vaishali Mehta Deutsche Bank Wealth Management 101 California Street Suite 2400 San Francisco. CA USA CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0079475 CONFIDENTIAL SDNY_GM_00225659 EFTA01380902

company Jawbone Stewart Oldfield Andrew Gallivan The Haze Trust 42500 Investment vehicle No change Yes No No Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bark Wealth Management • • • n Francisco. CA USA CONFIDENTIAL - PURSUANT TO FED. R. CRIM.

No change Yes No No Regards, Vaishali Mehta Head of Anti-Money Laundering Business Risk Deutsche Bark Wealth Management • • • n Francisco. CA USA CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0074282 CONFIDENTIAL SDNY_GM_00220466 EFTA01377443